This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

AbbVie (ABBV) took a big hit after an adult schizophrenia drug missed its primary endpoint in mid-stage trials. Analysts are ...

AbbVie has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and ...

AbbVie stock fell 10% after emraclidine, its drug for schizophrenia, failed during the final stages of its trials. The ...

Confidence in the company rose as shares for both AbbVie and its parent company, Abbott Laboratories, increased on the first day of trading in the New Year. AbbVie's stock opened yesterday at US $ ...

You can be a little greedy sometimes and find great stocks that possess solid growth prospects and also pay dividends.

However, arguably the next best thing is for a company to belong to the elite group known as Dividend Kings. To qualify, a ...

Keith Speights (AbbVie): If you like Abbott, you might love AbbVie. The big drugmaker spun off from Abbott in 2013. Since then, it has increased its dividend by a whopping 288%. Thanks to the time ...

And since it split from Abbott in 2013, AbbVie has raised its payout by 288%. The ability to maintain a solid dividend program for years is an incredibly attractive quality to long-term investors.

AbbVie, therefore, inherits the rich dividend history of its parent. In September, Abbott announced its 52nd consecutive annual dividend increase. Last week, AbbVie followed suit with its latest ...

Abbott Laboratories began paying dividends more than a century ago. AbbVie offers something for nearly every investor. Johnson & Johnson is an especially good pick for risk-averse investors.

Certifications such as the Good Housekeeping Seal help consumers know which products are safe and perform well. Unfortunately, no Good Housekeeping Seal exists for dividend stocks. However ...